支付方-提供方合资企业对医疗保健价值的影响。

IF 3.1 2区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Laura F Garabedian, J Frank Wharam, Joseph P Newhouse, Matthew Lakoma, Stephanie Argetsinger, Fang Zhang, Alison A Galbraith
{"title":"支付方-提供方合资企业对医疗保健价值的影响。","authors":"Laura F Garabedian, J Frank Wharam, Joseph P Newhouse, Matthew Lakoma, Stephanie Argetsinger, Fang Zhang, Alison A Galbraith","doi":"10.1111/1475-6773.14400","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To examine how a novel payer-provider joint venture (JV) between one payer and multiple competitive delivery systems in New Hampshire (NH), which included value-based payment, care management, and non-financial supports, impacted healthcare value and payer and provider group experiences.</p><p><strong>Study setting and design: </strong>We conducted a mixed-methods study. We used a quasi-experimental longitudinal difference-in-differences design to examine the impact of the JV (which started in January 2016 and ended in December 2020) on healthcare utilization, quality, and spending, using members in Maine (ME) as a control group. We also analyzed patient uptake of the JV's care management program using routinely collected administrative data and assessed payer and provider group leaders' perspectives about the JV via semi-structured interviews.</p><p><strong>Data sources and analytic sample: </strong>We used administrative and claims data from 2013 to 2019 in a commercially insured population under 65 years in NH and ME. We also used administrative data on care management eligibility and uptake and conducted semi-structured interviews with payer and provider group leaders affiliated with the JV.</p><p><strong>Principal findings: </strong>The JV was associated with no sustained change in medical utilization, quality, and spending throughout the study period. In the first year of the JV, there was a $142 (95% confidence interval: $41, $243) increase in pharmaceutical spending per member and a 13% (4.4%, 25%) relative increase in days covered for diabetes medications. Only 15% of eligible members engaged in care management, which was a key component of the JV's multi-pronged approach. In a disconnect from the empirical findings, payer and provider group leaders believed that the JV reduced healthcare costs and improved quality.</p><p><strong>Conclusions: </strong>Our findings provide evidence for future payer-provider JVs and demonstrate the importance of having a valid control group when evaluating JVs and value-based payment arrangements.</p>","PeriodicalId":55065,"journal":{"name":"Health Services Research","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of a payer-provider joint venture on healthcare value.\",\"authors\":\"Laura F Garabedian, J Frank Wharam, Joseph P Newhouse, Matthew Lakoma, Stephanie Argetsinger, Fang Zhang, Alison A Galbraith\",\"doi\":\"10.1111/1475-6773.14400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To examine how a novel payer-provider joint venture (JV) between one payer and multiple competitive delivery systems in New Hampshire (NH), which included value-based payment, care management, and non-financial supports, impacted healthcare value and payer and provider group experiences.</p><p><strong>Study setting and design: </strong>We conducted a mixed-methods study. We used a quasi-experimental longitudinal difference-in-differences design to examine the impact of the JV (which started in January 2016 and ended in December 2020) on healthcare utilization, quality, and spending, using members in Maine (ME) as a control group. We also analyzed patient uptake of the JV's care management program using routinely collected administrative data and assessed payer and provider group leaders' perspectives about the JV via semi-structured interviews.</p><p><strong>Data sources and analytic sample: </strong>We used administrative and claims data from 2013 to 2019 in a commercially insured population under 65 years in NH and ME. We also used administrative data on care management eligibility and uptake and conducted semi-structured interviews with payer and provider group leaders affiliated with the JV.</p><p><strong>Principal findings: </strong>The JV was associated with no sustained change in medical utilization, quality, and spending throughout the study period. In the first year of the JV, there was a $142 (95% confidence interval: $41, $243) increase in pharmaceutical spending per member and a 13% (4.4%, 25%) relative increase in days covered for diabetes medications. Only 15% of eligible members engaged in care management, which was a key component of the JV's multi-pronged approach. In a disconnect from the empirical findings, payer and provider group leaders believed that the JV reduced healthcare costs and improved quality.</p><p><strong>Conclusions: </strong>Our findings provide evidence for future payer-provider JVs and demonstrate the importance of having a valid control group when evaluating JVs and value-based payment arrangements.</p>\",\"PeriodicalId\":55065,\"journal\":{\"name\":\"Health Services Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Services Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/1475-6773.14400\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Services Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1475-6773.14400","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

目的考察新罕布什尔州(NH)一家支付方与多家竞争性医疗服务提供系统之间的新型支付方-医疗服务提供方合资企业(JV)(包括基于价值的支付、护理管理和非财务支持)如何影响医疗保健价值以及支付方和医疗服务提供方的体验:我们进行了一项混合方法研究。我们采用了准实验性纵向差异设计,以缅因州(Maine)的成员为对照组,考察了联合医疗计划(2016 年 1 月开始,2020 年 12 月结束)对医疗利用率、质量和支出的影响。我们还利用日常收集的行政数据分析了患者对联合医疗机构护理管理项目的接受情况,并通过半结构化访谈评估了支付方和医疗机构集团领导对联合医疗机构的看法:我们使用了 2013 年至 2019 年新罕布什尔州和密歇根州 65 岁以下商业保险人口的管理和索赔数据。我们还使用了有关护理管理资格和使用情况的行政数据,并对与合资企业有关联的支付方和医疗服务提供者团体领导进行了半结构化访谈:主要研究结果:在整个研究期间,联合医疗机构在医疗利用率、医疗质量和医疗支出方面没有发生持续变化。在合资公司成立的第一年,每名成员的药品支出增加了 142 美元(95% 置信区间:41 美元,243 美元),糖尿病药物治疗天数相对增加了 13%(4.4%,25%)。只有 15%的合格会员参与了护理管理,而这正是合资企业多管齐下方法的关键组成部分。与实证研究结果不符的是,支付方和医疗服务提供者团体的领导者认为,合资企业降低了医疗成本,提高了医疗质量:我们的研究结果为未来的支付方-提供方联合机构提供了证据,并证明了在评估联合机构和以价值为基础的支付安排时设立有效对照组的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The impact of a payer-provider joint venture on healthcare value.

Objective: To examine how a novel payer-provider joint venture (JV) between one payer and multiple competitive delivery systems in New Hampshire (NH), which included value-based payment, care management, and non-financial supports, impacted healthcare value and payer and provider group experiences.

Study setting and design: We conducted a mixed-methods study. We used a quasi-experimental longitudinal difference-in-differences design to examine the impact of the JV (which started in January 2016 and ended in December 2020) on healthcare utilization, quality, and spending, using members in Maine (ME) as a control group. We also analyzed patient uptake of the JV's care management program using routinely collected administrative data and assessed payer and provider group leaders' perspectives about the JV via semi-structured interviews.

Data sources and analytic sample: We used administrative and claims data from 2013 to 2019 in a commercially insured population under 65 years in NH and ME. We also used administrative data on care management eligibility and uptake and conducted semi-structured interviews with payer and provider group leaders affiliated with the JV.

Principal findings: The JV was associated with no sustained change in medical utilization, quality, and spending throughout the study period. In the first year of the JV, there was a $142 (95% confidence interval: $41, $243) increase in pharmaceutical spending per member and a 13% (4.4%, 25%) relative increase in days covered for diabetes medications. Only 15% of eligible members engaged in care management, which was a key component of the JV's multi-pronged approach. In a disconnect from the empirical findings, payer and provider group leaders believed that the JV reduced healthcare costs and improved quality.

Conclusions: Our findings provide evidence for future payer-provider JVs and demonstrate the importance of having a valid control group when evaluating JVs and value-based payment arrangements.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Services Research
Health Services Research 医学-卫生保健
CiteScore
4.80
自引率
5.90%
发文量
193
审稿时长
4-8 weeks
期刊介绍: Health Services Research (HSR) is a peer-reviewed scholarly journal that provides researchers and public and private policymakers with the latest research findings, methods, and concepts related to the financing, organization, delivery, evaluation, and outcomes of health services. Rated as one of the top journals in the fields of health policy and services and health care administration, HSR publishes outstanding articles reporting the findings of original investigations that expand knowledge and understanding of the wide-ranging field of health care and that will help to improve the health of individuals and communities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信